Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.
52W High
$39.59
52W Low
$21.18
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.60
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
9.77
EV/EBITDA (<8 favorable)
19.89
EV/Revenue (<3 favorable)
1.89
P/S (TTM) (<3 favorable)
1.15
P/B (<3 favorable)
1.71
Ownership
Institution‑heavySource: Overview
Insiders (1–5% typical)
0.37%
Institutions (25–75% balanced)
102.31%
Shares Outstanding
513,621,000
Float
511,474,000
Dividend Yield (2–6% sweet spot)
0.03%
Ex‑Dividend Date
2025-08-29
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
10,887,000,000
Gross Profit (TTM)
4,229,000,000
EPS (TTM)
-0.48
Profit Margin (>10% good)
-0.01%
Operating Margin (TTM) (higher better)
0.15%
ROE (TTM) (>15% strong)
-0.03%
EPS YoY (Quarterly) (>10% good)
2.38
Revenue YoY (Quarterly) (>8% good)
0.04
Momentum
Bearish momentumValue
-0.3067
Previous
-0.3076
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025